KLRS
Kalaris Therapeutics, Inc.
$4.71
-0.12 (-2.48%)
At close · Jul 8
Market Cap
$106.83M
Shares
23,792,278
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Laurie Keating | member of the Board | Appointed | 2026-07-06 |
| Morana Jovan-Embiricos, Ph.D. | member of the Company's board of directors | Resigned | 2026-07-06 |